Agilent Technologies Acquires Qiming-backed Biotechnology Firm ACEA Biosciences

US-based Agilent Technologies has signed a definitive agreement to acquire privately-owned biotechnology company ACEA Biosciences for $250 million in cash.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

1 COMMENT

LEAVE A REPLY